Arch Biopartners has an EPS of $-0.053. In 2022, the company made an earnings per share (EPS) of $-0.023. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.053 | 130.43% |
2022 | -$0.023 | 21.05% |
2021 | -$0.019 | -75.32% |
2020 | -$0.077 | - |